• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • AZ' COPD therapy wins US approval pharmatimes
    July 27, 2020
    AstraZeneca has bagged a green light in the US for Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) as maintenance treatment for patients with chronic obstructive pulmonary disease (COPD), the third leading cause of death globally.
  • Breztri Aerosphere cut rate of COPD exacerbations in PhIII trial pharmatimes
    June 30, 2020
    AstraZeneca’s triple-combination therapy Breztri Aerosphere (budesonide/glycopyrronium/formoterol fumarate) significantly cut the rate of moderate or severe exacerbations compared with two dual-combination therapies in patients with ...

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service